An observational study in Prostate Cancer (Adenocarcinoma), sponsored by F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica. Enrolling by invitation at 1 site in Slovakia. Open to male participants. Per ClinicalTrials.gov, last updated 2026-04-27.
Sponsored by F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica · Observational
The aim of the present project is to evaluate long-term oncological and functional treatment outcomes, as well as patient satisfaction, ten years after radical prostatectomy in patients initially enrolled in CPRRP study. This research builds on a previous five-year follow-up evaluation (approved by the ethics committee) and focuses on the durability of therapeutic effects, quality of life, and long-term complications. Data will be collected via telephone interviews assessing key parameters (PSA levels, information on subsequent radiotherapy and androgen-deprivation therapy, the ICIQ-SF and IIEF-5 questionnaires, and patient-reported quality-of-life and satisfaction measures), followed by statistical analysis.
7,046 studies on the registry are indexed under Prostatic Neoplasms; 1,580 are open to participants now.
This study's planned enrollment of 120 is below the median of 200 across 1,310 observational studies indexed under Prostatic Neoplasms.
Browse Prostatic Neoplasms studies →F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica is the lead sponsor of 9 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All participats of the initial CPRRS study
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-
Robot assisted radical prostatectomy
Biochemical recurrence
Prostate cancer biochemical recurrence rate
Time frame: From treatment to 10 years.
Incontinence rate
Postprostatectomy incontinence
Time frame: From surgery until 10 years.
Erectile dysfunction rate
Postprostatectomy erectile dysfunction rate
Time frame: From surgery until 10 years.
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Feb 2027, 12 months after the start.
Of 541 non-industry observational studies under Prostatic Neoplasms, half reached primary completion within 67 months of starting (the median), counting those still running; a quarter within 29 and three quarters within 162. This study's planned 12 months is below that.
Counting every sponsor, half of 650 studies reached it within 60 months; a quarter within 29 and three quarters within 141.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica